Preparing Your Plan for the GLP 1 Era: A Strategic Roadmap

By Emma

Preparing your plan for the GLP

Preparing Your Plan for the GLP 1 Era
Preparing Your Plan for the GLP 1 Era

Preparing your plan for the GLP-1 era After revolutionizing care for diabetes and weight loss, GLP-1 drugs are being eyed for more. Can we afford it? July 11, 2024 | 5-minute read

Mechanisms by which GLP 1 agonists may exert beneficial effects on
Mechanisms by which GLP 1 agonists may exert beneficial effects on

With more drugs and expanded indications on the way, pharmacy benefit providers need a defined strategy to manage these expensive GLP-1 agonists.

Obesity as a Chronic Disease

Study Reveals Impact on Utilization and Cost of Point of Sale Diagnosis Verification of GLP 1s
Study Reveals Impact on Utilization and Cost of Point of Sale Diagnosis Verification of GLP 1s

Though GLP-1 receptor agonists have existed for two decades, newer, more effective versions have transformed obesity care within just a few years—enabling 15 to 20 percent weight loss compared to the 5 percent with earlier generations. Yet with the swiftness of these therapies' arrival, most physicians lack access to evidence-based training on how to prescribe them effectively and safely ...

What self-funded employers should know As the GLP-1 space continues to evolve and per-prescription prices come down, overall plan costs can still go up.

GLP 1 Agonists and Lymphoproliferative Disorders in Adults Safety Evidence Bolt Pharmacy
GLP 1 Agonists and Lymphoproliferative Disorders in Adults Safety Evidence Bolt Pharmacy

Information for Part D Plans

FAQs for Part D Plans GENERAL What is the Medicare GLP-1 Bridge? The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1 , 2026, and December 31, 2027.

The Centers for Medicare & Medicaid Services (CMS) is expanding access to certain GLP-1 medications for people with Medicare Part D through the Medicare GLP-1 Bridge short-term demonstration starting July 1 , 2026. Medicare GLP-1 Bridge will operate outside of Medicare Part D plan coverage and use a central processor to manage prior authorization, claims processing, and pharmacy payment. The ...

Nutritional Priorities to Support GLP 1 Therapy for Obesity A Joint Advisory From the American
Nutritional Priorities to Support GLP 1 Therapy for Obesity A Joint Advisory From the American

How health systems are preparing for Medicare's GLP

Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.

Medicare weight loss coverage 2026, CMS BALANCE model, $50 GLP-1 copay, Medicare GLP-1 Wegovy eligibility, Part D out of pocket cap 2026.

GLP 1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
GLP 1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease

The GLP

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations may emerge in the years ahead.

Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists and Sodium Glucose
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists and Sodium Glucose
Frontiers
Frontiers
The Ultimate Guide to GLP 1 Peptides What They Are How They Work and Why They Matter
The Ultimate Guide to GLP 1 Peptides What They Are How They Work and Why They Matter
GLP 1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2
GLP 1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2
Evolving Role of Double and Triple Therapy With GLP 1 Receptor Agonists in Obesity
Evolving Role of Double and Triple Therapy With GLP 1 Receptor Agonists in Obesity
Understand GLP 1 GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy
Understand GLP 1 GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy

Learn how the Medicare GLP-1 Bridge works for prescribers—clinical criteria, prior authorization steps, and covered drugs. Starts July 1 , 2026.